Guangdong Kanghua Healthcare Group Co., Ltd.

SEHK:3689 Stock Report

Market Cap: HK$601.9m

Guangdong Kanghua Healthcare Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Guangdong Kanghua Healthcare Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth19.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Guangdong Kanghua Healthcare Group Co., Ltd.'s (HKG:3689) Popularity With Investors Is Under Threat From Overpricing

Dec 20
Guangdong Kanghua Healthcare Group Co., Ltd.'s (HKG:3689) Popularity With Investors Is Under Threat From Overpricing

Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly

Nov 25
Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly

There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings

Sep 30
There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Jun 10
Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

May 22
Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Nov 28
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

May 09
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Feb 02
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Nov 08
Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Sep 06
Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

May 31
Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Jan 25
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Sep 21
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

May 03
Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Feb 04
Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Guangdong Kanghua Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:3689 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20242,0395193190N/A
3/31/20242,0408683197N/A
12/31/20232,04212173204N/A
9/30/20232,00611876219N/A
6/30/20231,97011580234N/A
3/31/20231,9088793227N/A
12/31/20221,84660106221N/A
9/30/20221,8955997225N/A
6/30/20221,9455987228N/A
3/31/20221,95076125281N/A
12/31/20211,95494162333N/A
9/30/20211,905103198369N/A
6/30/20211,856112233405N/A
3/31/20211,80043173340N/A
12/31/20201,745-25113275N/A
9/30/20201,774-63-8167N/A
6/30/20201,802-100-12859N/A
3/31/20201,879-13-12478N/A
12/31/20191,95674-12198N/A
9/30/20191,885112-29153N/A
6/30/20191,81515062207N/A
3/31/20191,72715974192N/A
12/31/20181,63916887177N/A
9/30/20181,56616973181N/A
6/30/20181,49217059185N/A
3/31/20181,441163N/A200N/A
12/31/20171,389157N/A214N/A
9/30/20171,338153N/A189N/A
6/30/20171,287149N/A163N/A
3/31/20171,264145N/A159N/A
12/31/20161,240141N/A155N/A
12/31/20151,064119N/A199N/A
12/31/2014985102N/A206N/A
12/31/2013859107N/A214N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 3689's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 3689's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 3689's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 3689's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 3689's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 3689's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 17:36
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Kanghua Healthcare Group Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ruyi TangBOCI Research Ltd.
Jing QiangChina International Capital Corporation Limited
Yue-Kwong LuiChina Renaissance Securities